Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 813-180-8 | CAS number: 5856-32-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- From November 08, 2011 to December 27, 2011
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: The study was conducted according to standard guidelines in compliance with GLP; adequate consistency between data, comments and conclusions.
Cross-reference
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 012
- Report date:
- 2012
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- A non-LLNA test is available and was included to avoid unnecessary testing according to the Regulation (EC) No 1907/2006.
Test material
Reference
- Name:
- Unnamed
- Type:
- Constituent
- Details on test material:
- - Name of test material: 12-hydroxystearic acid
- Physical state: pale yellow solid (flakes)
- Lot/batch No.: 10B2122
- Expiry date: April 2012
- Storage condition: at room temperature.
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- male/female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: breeder: Charles River Laboratories France, L’Arbresle, France
- Age at study initiation: at the beginning of the treatment period, the animals of the main test were 5 weeks old
- Mean body weight at study initiation: the males had a mean body weight of 326 g (range: 298 g to 351 g) and the females a mean body weight of 308 g (range: 282 g to 328 g)
- Fasting period before study: no
- Housing: polycarbonate cages with stainless steel lid
- Diet: 106 pelleted diet (free access)
- Water: tap water filtered with a 0.22 µm filter (free access)
- Acclimation period: at least 5 days before the beginning of the study.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 2°C
- Humidity (%): 50 ± 20%
- Air changes (per hr): approximately 12 cycles/hour of filtered, non-recycled air
- Photoperiod (hrs dark / hrs light): 12 h/12 h (7:00 - 19:00).
IN-LIFE DATES: 08 November 2011 to 27 December 2011.
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal and epicutaneous
- Concentration / amount:
- Induction phase:
Concentration for intradermal injection: 2.5% *
Concentration for topical application: 10% *
*: highest to cause mild-to-moderate skin irritation based on preliminary assays
Challenge phase:
Concentration for topical application: 2.5%**
** highest non-irritant concentration based on preliminary assays
Challengeopen allclose all
- Route:
- epicutaneous, occlusive
- Concentration / amount:
- Induction phase:
Concentration for intradermal injection: 2.5% *
Concentration for topical application: 10% *
*: highest to cause mild-to-moderate skin irritation based on preliminary assays
Challenge phase:
Concentration for topical application: 2.5%**
** highest non-irritant concentration based on preliminary assays
- No. of animals per dose:
- - preliminary test: 6 treated animals
- main test: 30 treated animals - Details on study design:
- MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 2
- Exposure period: topical induction: 48 h
- Site: interscapular region
- Frequency of applications: once intradermal, once topical.
B. CHALLENGE EXPOSURE
- No. of exposures: 1
- Day(s) of challenge: 4 weeks between injection (induction) and challenge
- Exposure period: 24h
- Site: right flank (test item) and left flank (vehicle)
- Evaluation (hr after challenge): 24, 48 and 72 h after removal of dressing. - Positive control substance(s):
- not required
- Remarks:
- mercaptobenzothiazole tested in another study
Results and discussion
In vivo (non-LLNA)
Resultsopen allclose all
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 2.5%
- No. with + reactions:
- 5
- Total no. in group:
- 10
- Clinical observations:
- discrete-moderate erythema
- Remarks on result:
- other: Reading: 1st reading. Hours after challenge: 24.0. Group: negative control. Dose level: 2.5%. No with. + reactions: 5.0. Total no. in groups: 10.0. Clinical observations: discrete-moderate erythema.
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 2.5%
- No. with + reactions:
- 6
- Total no. in group:
- 10
- Clinical observations:
- discrete-moderate erythema
- Remarks on result:
- other: Reading: 2nd reading. Hours after challenge: 48.0. Group: negative control. Dose level: 2.5%. No with. + reactions: 6.0. Total no. in groups: 10.0. Clinical observations: discrete-moderate erythema.
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 2.5%
- No. with + reactions:
- 7
- Total no. in group:
- 20
- Clinical observations:
- discrete-moderate erythema
- Remarks on result:
- other: Reading: 1st reading. Hours after challenge: 24.0. Group: test group. Dose level: 2.5%. No with. + reactions: 7.0. Total no. in groups: 20.0. Clinical observations: discrete-moderate erythema.
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 2.5%
- No. with + reactions:
- 9
- Total no. in group:
- 20
- Clinical observations:
- discrete-moderate erythema
- Remarks on result:
- other: Reading: 2nd reading. Hours after challenge: 48.0. Group: test group. Dose level: 2.5%. No with. + reactions: 9.0. Total no. in groups: 20.0. Clinical observations: discrete-moderate erythema.
Applicant's summary and conclusion
- Interpretation of results:
- other: doubtful
- Remarks:
- Criteria used for interpretation of results: EU
- Conclusions:
- The potential of the test substance to induce delayed contact hypersensitivity in guinea pigs remained doubtful. In order to conclude, a further study should be carried out using a lower concentration for the challenge application.
- Executive summary:
The objective of this study was to evaluate the potential of the test substance, 12-hydroxystearic acid, to induce delayed contact hypersensitivity in guinea pigs according to the maximization method of Magnusson and Kligman and to OECD Guideline 406 (17th July 1992) and Commission Regulation (EC) (No. 440/2008, B.6, 30 May 2008). This study was conducted in compliance with the principles of Good Laboratory Practice.
A preliminary test was first performed in order to determine the test item concentrations to be used in the main test.
In the main test, 30 guinea pigs were allocated to 2 groups: a control group of 5 males and 5 females and a treated group of 10 males and 10 females.
On Day 1, three pairs of intradermal injections were performed in the interscapular region of animals:
. Freund's Complete Adjuvant (FCA) diluted to 50% (v/v) with 0.9% NaCl,
. test item at the concentration of 2.5% in corn oil (treated group) or vehicle alone (control group),
. test item at the concentration of 2.5% in a mixture FCA/0.9% NaCl (50/50, w/w) (treated group) or vehicle at the concentration of 50% (w/v) in FCA/0.9% NaCl (50/50, v/v) (control group).
As in the preliminary test, the highest well-tolerated concentration was shown to be slightly irritant after topical application, 0.5 mL of sodium lauryl sulfate at 10% (w/w) in vaseline was applied to the induction site on Day 7 in order to induce a local irritation.
On Day 8, a filter paper (approximately 8 cm2) was fully-loaded with the test item at the concentration of 10% (w/w) in corn oil, and then applied to the clipped interscapular region, over the intradermal injection sites. The filter paper was held in place by means of an occlusive dressing for 48 h. The presence of local irritation was checked (but not scored). The control group animals received an application of the vehicle under the same experimental conditions.
The induction phase was followed by a 14 day rest period.
On Day 22, all animals of both groups were challenged by a cutaneous application of the test item at the concentration of 2.5% (w/w) in corn oil to the right flank. The chamber was held in contact with the skin by an occlusive dressing for 24 h. The vehicle was applied to the left flank under the same experimental conditions.
Cutaneous reactions were evaluated before treatment and 24, 48 and 72 h after removal of the dressing.
Each animal was observed at least once a day for mortality and clinical signs during the treatment and observation periods. Bodyweight was recorded on Day 1 and at the end of each observation period.
Upon completion of the observation period, the animals were sacrificed then discarded without macroscopic post-mortem examination. For all animals, skin samples of the challenged application sites were preserved. No microscopic examination was performed.
Results can be summarised as follows:
Mortality, clinical signs and body weight
No unscheduled deaths occurred during the main test.
No clinical signs indicative of systemic toxicity were observed in any animals.
The bodyweight change of the treated animals was similar to that of controls.
Cutaneous reactions
At the 24 h reading, after the challenge application, no cutaneous reaction was observed on the left flank of control animals (vehicle application). Discrete or moderate erythema were noted on the right flank (test item-treated) of 5/10 control animals.
In the test item-treated group, at the 24 h reading, a discrete erythema was noted on the left flank (vehicle treated) of one male only. A discrete or moderate erythema was noted on the right flank (test item‑treated) of 7/20 animals.
At the 48 h reading, a discrete or moderate erythema was observed on the left flank of 4/10 control animals (vehicle application). Discrete or moderate erythema were noted on the right flank (test substance‑treated) of 6/10 control animals.
In the test substance-treated group, at the 48 h reading, a discrete erythema was noted on the left flank (vehicle treated) of 6/20 animals. A discrete or moderate erythema was noted on the right flank (test substance‑treated) of 9/20 animals.
The increase in the incidence and severity of cutaneous reactions on both flanks was correlated with the shaving of the flanks after the 24 h reading.
At the 72 h reading, a discrete erythema was observed on the left flank (vehicle application) of only three males of the control group. Discrete or moderate erythema was noted on the right flank (test substance‑treated) of the same males.
In the test substance-treated group, at the 72 h reading, a discrete or moderate erythema was noted on the left flank (vehicle treated) of 5/20 animals. A discrete erythema sometimes associated with dryness of the skin was noted on the right flank (test substance-treated) of 6/20 animals.
At each observation time, dryness of the skin was observed in both group, associated with erythema or not.
It was not possible to determine the incidence of sensitisation responses in the induced test substance-treated group as:
. after the 24 h observation, the shaving of the flanks elicited cutaneous reactions on the left flank (vehicle treated) of all animals,
. the skin reactions seen on the right flank (test substance-treated) of the control group animals were indicative of skin irritation since none of these animals were exposed to the test substance prior to the topical challenge.
The concentration of the test substance selected for the topical challenge was too high.
Following these observations, it was therefore not possible to give a clear conclusion on this study.
Conclusion
The potential of the test substance to induce delayed contact hypersensitivity in guinea pigs remained doubtful.
In order to conclude on the dermal sensitization potential of the test substance, a further study should be carried out using a lower concentration for the challenge application.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.